Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Multiple Myeloma Cell Defects Erythropoiesis and Results Anemia Via High Level of CCL3 in Bone Marrow Microenvironment

Lanting Liu, Zhen Yu, MD, Hui Cheng, Weiwei Sui, Shuhui Deng, MD, Xiaojing Wei, Chenxing Du, MD, Wenyang Huang, Gang An, Wen Zhou, PhD, Tao Cheng, Lugui Qiu, MD, Mu Hao

Blood (2020) 136 (Supplement 1): 55.

https://doi.org/10.1182/blood-2020-139006

Published: 2020

Journal Articles

Alterations of Gut Microbiome Accelerate Multiple Myeloma Progression By Increasing the Relative Abundances of Nitrogen Recycling Bacteria

Xingxing Jian, PhD, Yinghong Zhu, Jian Ouyang, Qian Lei, Jiliang Xia, PhD, Jingyu Zhang, Jiaojiao Guo, Jinuo Wang, MD, Jingchao Lin, Mingming Su, Yongjun Guan, Guancheng Li, PhD, Minghua Wu, PhD, Jian Li, MD, Juanjuan Xiang, PhD, Lu Xie, PhD, Lugui Qiu, MD PhD, Wei Jia, PhD, Wen Zhou, PhD

Blood (2019) 134 (Supplement_1): 688.

https://doi.org/10.1182/blood-2019-125051

Published: 2019

Journal Articles

Excess Serine from the Microenvironment Caused the Impaired Megakaryopoiesis and Thrombocytopia in Multiple Myeloma

Chunmei Kuang, Meijuan Xia, Gang An, MD, Cuicui Liu, Dan Wu, Pei Su, Jingyu Zhang, Jiliang Xia, PhD, Jiaojiao Guo, Xuan Wu, Wei Jia, PhD, Lugui Qiu, MD PhD, Wen Zhou, PhD, Jiaxi Zhou

Blood (2019) 134 (Supplement_1): 4331.

https://doi.org/10.1182/blood-2019-125289

Published: 2019

Journal Articles

NEK2 Promotes Bortezomib Resistance through Enhancing Autophagy By Upregulation of Beclin1 in Multiple Myeloma Cells

Jiliang Xia, PhD, Yanjuan He, MD, Bin Meng, Jingyu Zhang, Xuan Wu, Xiangling Feng, PhD, Chunmei Kuang, Jiaojiao Guo, Yinghong Zhu, Qian Lei, Yongjun Guan, Yi Shen, MD PhD, Lugui Qiu, MD PhD, Wen Zhou, PhD

Blood (2019) 134 (Supplement_1): 4332.

https://doi.org/10.1182/blood-2019-126617

Published: 2019

Journal Articles

High Glycine Promotes Proliferation and Progression Though Increase of Glutathione Synthesis in Multiple Myeloma

Jiliang Xia, PhD, Jingyu Zhang, Bin Meng, Xuan Wu, Qian Lei, Yinghong Zhu, Yanjuan He, MD, Lugui Qiu, MD PhD, Wei Jia, PhD, Wen Zhou, PhD

Blood (2019) 134 (Supplement_1): 1791.

https://doi.org/10.1182/blood-2019-125452

Published: 2019

Journal Articles

Potential Metabolite Markers of Multiple Myeloma

Jiliang Xia, PhD, Jingyu Zhang, Xuan Wu, ShiLian Chen, Jingchao Lin, Mingming Su, Jiaojiao Guo, Yongjun Guan, Minghua Wu, Lugui Qiu, MD, Fenghuang Zhan, MD, Wen Zhou, PhD

Blood (2018) 132 (Supplement 1): 3163.

https://doi.org/10.1182/blood-2018-99-115934

Published: 2018

Journal Articles

High Expression of NEK2 Mediated By p53 Contributes to Progression and Relapse of Multiple Myeloma

Wen Zhou, PhD, Fenghuang Zhan, MD PhD

Blood (2018) 132 (Supplement 1): 192.

https://doi.org/10.1182/blood-2018-192

Published: 2018

Journal Articles

Single-Cell Analysis Reveals Sequential Genetic Events from Hematopoietic Stem Cell Differentiation Hierarchy in Multiple Myeloma Patients with FGFR3/IGH Translocation

Wen Zhou, PhD, Fenghuang Zhan, MD PhD

Blood (2018) 132 (Supplement 1): 5598.

https://doi.org/10.1182/blood-2018-99-115606

Published: 2018

Journal Articles

AURKA Regulates the Mechanism of ATR Mediated DNA Damage Response about Drug Resistance in Multiple Myeloma

Zhang Shuaishuai, MD, Yu Qin, An Gang, MD, Mu Hao, PhD, Yan Xu, MD, Shuhui Deng, Tengteng Yu, Wen Zhou, Lugui Qiu, MD

Blood (2017) 130 (Supplement 1): 5354.

https://doi.org/10.1182/blood.V130.Suppl_1.5354.5354

Published: 2017

Journal Articles

Suppression of Cdc37 Induces BTZ Resistance through XBP1s Mediated Plasma Cell Immaturation in Multiple Myeloma

Meirong Zang, Lanting LIU, Fengyan Jin, Jiaojiao Guo, An Gang, MD, Xiaoqi Qin, Tao Zhu, Shuhui Deng, Zhang Shuaishuai, MD, Mu Hao, PhD, Xiaoyan Feng, Yan Xu, MD, Wen Zhou, Lugui Qiu, MD

Blood (2017) 130 (Supplement 1): 4350.

https://doi.org/10.1182/blood.V130.Suppl_1.4350.4350

Published: 2017

Journal Articles

Lycorine Downregulates HMGB1 to Inhibit Autophagy and Enhances Bortezomib Activity in Multiple Myeloma

Mridul Roy, Long Liang, Xiaojuan Xiao, Yuanliang Peng, Yuhao Luo, Weihua Zhou, Ji Zhang, Lugui Qiu, Shuaishuai Zhang, Feng Liu, Xiuli An, MD PhD, Mao Ye, Wen Zhou, PhD, Jing Liu, PhD

Blood (2016) 128 (22): 3265.

https://doi.org/10.1182/blood.V128.22.3265.3265

Published: 2016

Journal Articles

Suppression of Cdc37 Induces Bortezomib Resistance through Autophagy Activation and Plasma Cell Immaturation in Multiple Myeloma

Meirong Zang, Fengyan Jin, Lanting Liu, Gang An, MDPhD, Xiaoqi Qin, MD, Xiaoyan Feng, Yan Xu, MDPhD, Mu Hao, MD PhD, Wen Zhou, PhD, Lugui Qiu, MD PhD

Blood (2015) 126 (23): 2480.

https://doi.org/10.1182/blood.V126.23.2480.2480

Published: 2015

Journal Articles

Pathological Roles of p18 Deficiency Toward B Cell Malignances

Sha Hao, PhD, Fang Dong, PhD, Wen Zhou, PhD, Hui Cheng, PhD, Shihui Ma, MD, Lugui Qiu, MD PhD, Tao Cheng, MD

Blood (2015) 126 (23): 2448.

https://doi.org/10.1182/blood.V126.23.2448.2448

Published: 2015

Journal Articles

Antitumor Activity of a Novel Proteasome Inhibitor BSc2118 Against Multiple Myeloma

Meirong Zang, PhD, Lanting Liu, Xin Li, Wei Li, MD, Ulrike Kuckelkorn, Wen Zhou, PhD, Lugui Qiu, MD, Fengyan Jin, MD

Blood (2014) 124 (21): 5725.

https://doi.org/10.1182/blood.V124.21.5725.5725

Published: 2014

Journal Articles

Unmeasurable Serum M-Protein Multiple Myeloma Benefit Less from Bortezomib Than Measurable Myeloma

Xiaoqi Qin, Gang An, MD PhD, Yan Xu, MD PhD, Yu Qin, PhD, Xiaoyan Feng, MD, Meirong Zang, PhD, Weiwei Sui, MD, Shuhui Deng, MD, Shuhua Yi, Wen Zhou, PhD, Lugui Qiu, MD

Blood (2014) 124 (21): 2062.

https://doi.org/10.1182/blood.V124.21.2062.2062

Published: 2014

Journal Articles

MiR-137 Contributes to Drug Susceptibility and Chromosomal Instability of Multiple Myeloma through Targeting AURKA

Yu Qin, PhD, Fei Li, MD, Xiaoqi Qin, Gang An, MD PhD, Mu Hao, PhD, Meirong Zang, PhD, Yan Xu, MD PhD, Wen Zhou, PhD, Hong Chang, Lugui Qiu, MD

Blood (2014) 124 (21): 5715.

https://doi.org/10.1182/blood.V124.21.5715.5715

Published: 2014

Journal Articles

Clonal Heterogeneityand Evolutional Paths in Multiple Myeloma Revealed By QM-FISH in Single Cell of Sequential Analysis

Xiaoqi Qin, Gang An, MD PhD, Yu Qin, PhD, Yan Xu, MD PhD, Xiaoyan Feng, MD, Meirong Zang, PhD, Weiwei Sui, MD, Shuhui Deng, MD, Shuhua Yi, Wen Zhou, PhD, Lugui Qiu, MD PhD

Blood (2014) 124 (21): 3395.

https://doi.org/10.1182/blood.V124.21.3395.3395

Published: 2014

Journal Articles

RARα2 expression confers myeloma stem cell features

Ye Yang, Jumei Shi, Giulia Tolomelli, Hongwei Xu, Jiliang Xia, He Wang, Wen Zhou, Yi Zhou, Satyabrata Das, Zhimin Gu, Dana Levasseur, Fenghuang Zhan, Guido Tricot

Blood (2013) 122 (8): 1437–1447.

https://doi.org/10.1182/blood-2013-02-482919

Published: 2013

Includes: Supplemental data

Journal Articles

Phase I Exploratory Study of IV Formulation of Panobinostat in Combination with Bortezomib in Relapsed/Refractory Multiple Myeloma Patients: Effect On Serum PTH and Gene Expression Profiling (GEP) Studies

Maurizio Zangari, MD, Tamara Berno, MD, Giampaolo Talamo, MD, Xin Zhan, Wen Zhou, He Wang, Ye Yang, PhD, Jiliang Xia, Yi Zhou, Karen Pena, Leanne Lujan, Jessica Kohan, Mohamed E Salama, M.D., Fenghuang Zhan, MD, PhD

Blood (2012) 120 (21): 4073.

https://doi.org/10.1182/blood.V120.21.4073.4073

Published: 2012

Journal Articles

NEK2 Regulates Immature B Cell Development and GC Formation in NEK2 Transgenic Mouse

Wen Zhou, PhD, Xiao He, He Wang, Mohamed E Salama, M.D., Xia Jiliang, Hongwei Xu, MD, MS, Maurizio Zangari, MD, Guido J. Tricot, MD, PhD, Fenghuang Zhan, MD, PhD

Blood (2012) 120 (21): 257.

https://doi.org/10.1182/blood.V120.21.257.257

Published: 2012

NARROW

Multiple Myeloma Cell Defects Erythropoiesis and Results Anemia Via High Level of CCL3 in Bone Marrow Microenvironment

Alterations of Gut Microbiome Accelerate Multiple Myeloma Progression By Increasing the Relative Abundances of Nitrogen Recycling Bacteria

Excess Serine from the Microenvironment Caused the Impaired Megakaryopoiesis and Thrombocytopia in Multiple Myeloma

NEK2 Promotes Bortezomib Resistance through Enhancing Autophagy By Upregulation of Beclin1 in Multiple Myeloma Cells

High Glycine Promotes Proliferation and Progression Though Increase of Glutathione Synthesis in Multiple Myeloma

Potential Metabolite Markers of Multiple Myeloma

High Expression of NEK2 Mediated By p53 Contributes to Progression and Relapse of Multiple Myeloma

Single-Cell Analysis Reveals Sequential Genetic Events from Hematopoietic Stem Cell Differentiation Hierarchy in Multiple Myeloma Patients with FGFR3/IGH Translocation

AURKA Regulates the Mechanism of ATR Mediated DNA Damage Response about Drug Resistance in Multiple Myeloma

Suppression of Cdc37 Induces BTZ Resistance through XBP1s Mediated Plasma Cell Immaturation in Multiple Myeloma

Lycorine Downregulates HMGB1 to Inhibit Autophagy and Enhances Bortezomib Activity in Multiple Myeloma

Suppression of Cdc37 Induces Bortezomib Resistance through Autophagy Activation and Plasma Cell Immaturation in Multiple Myeloma

Pathological Roles of p18 Deficiency Toward B Cell Malignances

Antitumor Activity of a Novel Proteasome Inhibitor BSc2118 Against Multiple Myeloma

Unmeasurable Serum M-Protein Multiple Myeloma Benefit Less from Bortezomib Than Measurable Myeloma

MiR-137 Contributes to Drug Susceptibility and Chromosomal Instability of Multiple Myeloma through Targeting AURKA

Clonal Heterogeneityand Evolutional Paths in Multiple Myeloma Revealed By QM-FISH in Single Cell of Sequential Analysis

RARα2 expression confers myeloma stem cell features

Phase I Exploratory Study of IV Formulation of Panobinostat in Combination with Bortezomib in Relapsed/Refractory Multiple Myeloma Patients: Effect On Serum PTH and Gene Expression Profiling (GEP) Studies

NEK2 Regulates Immature B Cell Development and GC Formation in NEK2 Transgenic Mouse

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only